Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy

Published:2015-06 Issue:6 Volume:41 Page:540-546
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Bosch-Barrera Joaquim^ORCID,Menendez Javier A.

Funder

Spanish Society of Medical Oncology

Ministerio de Ciencia e Innovación

Agència de Gestió d’Ajuts Universitaris i de Recerca

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference65 articles.

1. STATs and gene regulation;Darnell;Science,1997

2. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein;Yu;Science,1995

3. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention;Buettner;Clin Cancer Res,2002

4. Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance;Quintás-Cardama;Clin Cancer Res,2013

5. Regulation of STAT-dependent pathways by growth factors and cytokines;Leaman;FASEB J,1996

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive astrocytes promote tumor progression by up-regulating tumor protocadherin 1 expression in lung cancer brain metastasis;Biochemical and Biophysical Research Communications;2024-11

2. Intelligent micelles for on-demand drug delivery targeting extracellular matrix of pancreatic cancer;Journal of Controlled Release;2024-09

3. Silibinin is a suppressor of the metastasis-promoting transcription factor ID3;Phytomedicine;2024-06

4. The importance of integrated therapies on cancer: Silibinin, an old and new molecule;Oncotarget;2024-05-23

5. Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma;BMC Cancer;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3